Related Experiment Videos
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune
T J Connor1, M G McNamara, D Finn
1Department of Pharmacology, University College Galway, Ireland.
Abstract:
(+)-3,4-Methylenedioxymethamphetamine (MDMA;'Ecstasy') is a ring substituted phenylisopropylamine that is structurally related to both amphetamines and hallucinogens. The unique behavioural activating properties of MDMA have led to its widespread abuse. MDMA induces many neurochemical, behavioural and endocrine alterations which closely resemble those elicited by exposure to acute stress, suggesting that MDMA could be regarded as a 'chemical stressor'. In addition to the neurochemical, behavioural and endocrine effects of stressor exposure, it has been reported that stress produces alterations in immune function. However, to date the effects of MDMA on immune function have been restricted to in vitro investigations. In this study we report, for the first time, that acute in vivo administration of MDMA (20 mg/kg, i.p.) produced a rapid (within 30 min) suppression of Con A-induced lymphocyte proliferation and a profound reduction in the total leucocyte count in rats that persisted for at least 6 h following injection. These alterations in immune function were accompanied by a significant increase in plasma corticosterone concentrations 30 min post MDMA administration which had returned to baseline values within 6 h of drug administration. In addition, there was a significant depletion in cortical 5-HT concentrations both 30 min and 6 h after MDMA administration. The results of this study provide evidence that in addition to the well established toxic effects of MDMA on the central serotonergic system, a single administration of this widely abused drug induces a rapid and sustained suppression of immune function.
Insights
(+)-3,4-Methylenedioxymethamphetamine (MDMA) rapidly suppresses immune function in rats. This study shows MDMA administration significantly reduces lymphocyte proliferation and white blood cell counts, alongside changes in stress hormones and serotonin levels.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- (+)-3,4-Methylenedioxymethamphetamine (MDMA), also known as Ecstasy, is a widely abused amphetamine derivative.
- MDMA's behavioral and neurochemical effects resemble those of acute stress, leading to its classification as a 'chemical stressor'.
- While stress impacts immune function, MDMA's in vivo effects on immunity were previously uninvestigated.
Purpose of the Study:
- To investigate the acute in vivo effects of MDMA administration on immune function in rats.
- To determine if MDMA exposure alters lymphocyte proliferation, leukocyte counts, corticosterone levels, and serotonin concentrations.
Main Methods:
- Rats were administered a single intraperitoneal injection of MDMA (20 mg/kg).
- Immune function was assessed by measuring Concanavalin A (Con A)-induced lymphocyte proliferation and total leukocyte count.
- Plasma corticosterone concentrations and cortical serotonin (5-HT) levels were measured at 30 minutes and 6 hours post-administration.
Main Results:
- Acute MDMA administration rapidly suppressed Con A-induced lymphocyte proliferation within 30 minutes.
- A profound reduction in total leukocyte count was observed, persisting for at least 6 hours.
- MDMA increased plasma corticosterone levels at 30 minutes, returning to baseline by 6 hours.
- Significant depletion of cortical serotonin concentrations was noted at both 30 minutes and 6 hours post-administration.
Conclusions:
- A single in vivo administration of MDMA induces rapid and sustained suppression of immune function in rats.
- These immunological changes are associated with alterations in the stress hormone system and central serotonergic pathways.
- The findings highlight MDMA's detrimental effects on both the central nervous system and immune system.